Table
1: Characteristics
of 33 patients with BCLM
Age at primary (year) |
46.2 (27 ~ 70) |
Stage |
0 2, Ⅰ 6, Ⅱ8, Ⅲ6, Ⅳ 9, unknown 2 |
Timing of liver metastases |
|
synchronous (n) |
6 |
metachronous
(n) |
27 |
interval from primary treatment (month) |
45.7 (9 ~ 227) |
Adjuvant therapy |
|
after primary operation |
C* + E† 11, C 8, E 4 |
prehepatic-operation |
C 5, C + E 3, E 2, C + T‡ 1, |
after liver operation |
C 12, C + T 8, C + E 6, E 2, C + T + E 1, T 1 |
Number of liver metastases (n) |
6.4 (1 ~ 31) |
Maximal tumor diameter(mm) |
38.9 (12.3 ~ 120.0) |
Type of liver operation |
MCN§ 14, HR¶ 11, HR + MCN 8 |
Extrahepatic metastatic disease |
|
before liver metastases |
bone 3, lung 1, LN# 1 |
at liver metastases |
LN 4, bone 5, lung 2 peritoneal dissemination 1, chest wall 1 |
after liver metastases |
bone 13, brain 5, LN 4, lung 4, ovary 3 |
*chemotherapy;
†endocrine therapy; ‡Trastuzumab; §microwave coagule-necrotic therapy; ¶hepatic
resection; #lymph node